Cite
APA Citation
Wu, X., Wang, J., Zhou, Q., Gu, T., Zhang, K., Liang, J., Mu, S., Ge, R., Yang, H., Huang, V., Brachmann, R., Wang, L., & Li, M. (n.d.). 998TiPPamiparib, a novel PARP 1/2 inhibitor, monotherapy for gBRCAm patients with recurrent ovarian, fallopian, and primary peritoneal cancer: An open-label, multicenter, phase II trial in China. Annals of oncology, 29, . http://access.bl.uk/ark:/81055/vdc_100095485662.0x000031